Xenobiotic-metabolizing enzymes in human lung

Current Drug Metabolism

Volumn 7, Issue 8, 2006, Pages 939-948

  Zhang, Ji Y ^a   Wang, YueFen ^b   Prakash, Chandra ^c  

^a GLAXOSMITHKLINE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Cytochrome P450; Human lung; Xenobiotic metabolizing enzymes

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; 7 PROPOXYCOUMARIN; ACYLTRANSFERASE; CARCINOGEN; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; CYTOCHROME P450 2A13; CYTOCHROME P450 2E1; CYTOCHROME P450 2F1; CYTOCHROME P450 3A5; CYTOCHROME P450 4B1; DIMETHYLANILINE MONOOXYGENASE; DRUG; DRUG METABOLIZING ENZYME; EPOXIDE HYDROLASE; ESTRADIOL; ESTROGEN SULFOTRANSFERASE; ETHOXYCOUMARIN; ETHOXYRESORUFIN; GLUTATHIONE TRANSFERASE; IRINOTECAN; PACLITAXEL; PENTOXYRESORUFIN; SULFOTRANSFERASE; THIOUREA; TOXIN; TRANSFERASE; UNINDEXED DRUG; XENOBIOTIC AGENT;

DRUG ACTIVATION; DRUG INACTIVATION; ENVIRONMENT; ENZYME ACTIVATION; GENETIC POLYMORPHISM; HUMAN; INTESTINE; KIDNEY; LIVER; LUNG; LUNG ALVEOLUS CELL; LUNG DISEASE; MEDICAL RESEARCH; METABOLISM; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; RISK FACTOR; UNSPECIFIED SIDE EFFECT;

CYTOCHROME P-450 ENZYME SYSTEM; EPOXIDE HYDROLASES; HUMANS; LUNG; METABOLIC DETOXICATION, PHASE I; METABOLIC DETOXICATION, PHASE II; OXYGENASES; TRANSFERASES; XENOBIOTICS;

EID: 33845348869     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920006779010575     Document Type: Review

References (133)

1. Reynolds, N.A; Lyseng-Williamson, K.A. and Wiseman, L.R. (2005) Drugs, 65, 1715-1734.
2. Strand, A.M. and Luckow, A. (2004) Respir. Med., 98, 1008-1015.
3. Derom, E. and Pauwels, P.A. (2005) Clin. Pharmacokinet., 44, 815-836.
4. Nelson, DR; Koymans, L.; Kamataki, T.; Stegeman, J.J.; Feyeresin, R.; Waxman, D.J.; Waterman, M.R.; Gotoh, O.; Coon,, M.J.; Estabrook, R.W.; Gunsalus, I.C. and Nebert D.W. (1996) Pharmacogenetics, 6, 1-42.
5. Guengerich, F.P. (1990) Pharmacol. Ther., 45, 299-307.
6. Gram, T.E. (1997) Pharmacol, Rev., 49, 287-341.
7. Dahl, A.R. and Hadley, W.M. (1991) Crit. Rev. Toxicol., 21, 345-272.
8. Foth, H. (1995) Crit. Rev. Toxicol., 25,165-205.
9. Parkinson, A. Biotransformation of xenobiotics, in Klaassen, C.D. (ed) Casarett & Doull's Toxicology: The basic science of poisons. New York: McGraw-Hill, Inc., 2001, pp. 133-224.
10. Ding, X. and Kaminsky, L.S. (2003) Annu. Rev. Pharmacol. Toxicol., 43, 149-173.
11. Gharavi, N. and El-Kadi A.O.S. (2004) Curr. Drug Metab., 5, 203-210.
12. Hukkanen, J.; Pelkonen, O. and Raunio, H. (2001) Eur. Respir. J., 19, Suppl. 32, 122S-126S.
13. Spivack, S.D.; Hurteau, G.J.; Fasco, M.J. and Kaminsky, L.S. (2003) Clin. Cancer Res., 9, 6002-6011.
14. Nemery, B.; Bast A.; Behr. J,; Borm, P.J.; Bourke, S.J.; Camus, P.H.; De Vuyst, P.; Jansen, H.M.; Kinnula, V.L.; Lison, D.; Pelkonen, O. and Saltini, C. (2001) Eur. Respir. J., 18(Suppl. 32), 30s-42s.
15. Danielson, P.B. (2002) Curr. Drug Metab., 3, 561-597.
16. Nelson, D.R.; Zeldin, D.C.; Hoffman, S.M.G.; Maltias, L.J.; Wain, H.M. and Nebert, D.W. (2004) Pharmacogenetics, 14, 1-18.
17. McManus, M.E.; Boobis, A.R.; Pacifici, G.M.; Frempong, R.Y.; Brodie, M.J.; Kang, G.C.; Whyte, C. and Davies, D.S. (1979) Life Sci., 26, 481-487.
18. Hukkanen, J.; Pelkonen, O.; Hakkola, J. and Raunio, H. (2002) Crit. Rev. Toxicol., 32, 391-411.
19. Wei, C.; Caccavale, R.J.; Kehoe, J.J.; Thomas, P.E. and Iba, M.M. (2001) Cancer Lett., 171, 113-120.
20. Willey, J.C.; Coy, E.L.; Frampton, M.W.; Torres, A.; Apostolakos, M.J.; Hoehn, G.; Schuermann, W.H.; Thilly, W.G.; Olson, D.E.; Hammersley, J.R.; Crespi, C.L. and Utell, M.J. (1997) Am. J. Respir. Cell Mol. Biol., 17, 114-124.
21. Tang, Y.M.; Chen G.F.; Thompson, P.A.; Lin, D.X.; Lang, N.P. and Kadlubar, F.K. (1999) Drug Metab. Dispos., 27, 274-280.
22. Shimada, T.; Yamazaki, H.; Mimura, M.; Wakamiya, N.; Ueng, Y.F.; Guengerich, F.P. and Inui, Y. (1996) Drug Metab. Dispos., 24, 515-522.
23. Crawford, E.L.; Weaver, D.A.; Demuth, J.P.; Jackson, D.M.; Khuder, S.A.; Frampton, M.W.; Utell, M.J.; Thilly, W.G. and Willey, J.C.. (1998) Carcinogenesis, 19, 1867-1871.
24. Su, T.; Bao, Z.P.; Zhang, Q.Y.; Smith, T.J.; Hong, J.Y. and Ding, X. (2000) Cancer Res., 60, 5074-5079.
25. Mace, K.; Bowman, E.D.; Vautravers, P.; Shields, P.G.; Harris, C.C. and Pfeifer, A.M. (1998) Eur. J. Cancer, 34, 914-920.
26. Guidice, J.M.; Marez, D.; Sabbagh, N.; Legrand-Andreoletti, M.; Spire, C.; Alcaide, E.; Lafitte, J.J. and Broly, F. (1997) Biochem. Biophys. Res. Commun., 241, 79-85.
27. Zeldin, D.C., Foley. J.; Ma, J.; Boyle, J.E.; Pascual, J.M.; Moomaw, C.R.; Tomer, K.B.; Steenbergen, C. and Wu, S. (1996) Mol. Pharmacol., 50, 1111-1117.
28. Rylander, T.; Neve, E.P.; Ingelman-Sundberg, M. and Oscarson, M. (2001) Biochem. Biophys. Res. Commun., 281, 529-535.
29. Westlind, A.; Malmebo, S.; Johansson, I.; Otter, C.; Andersson, T.B.; Ingelman-Sundberg, M. and Oscarson, M. (2001) Biochem. Biophys. Res. Commun., 282, 1349-1355.
30. Nhamburo, P.T.; Kimura, S.; McBride, O.W.; Kozak, C.A.; Gelboin, H.V. and Gonzalez, F.J. (1990) Biochemistry, 29, 5491-5499.
31. Anttila, S.; Hukkanen, J.; Hakkola, J.; Stjernvall, T.; Beaune, P.; Edwards, R.J.; Boobis, A.R.; Pelkonen, O. and Raunio, H. (1997) Am. J. Respir. Cell. Mol. Biol., 16, 242-249.
32. Nhamburo, P.T.; Gonzalez, F.J.; McBride, O.W.; Gelboin, H.V. and Kimura, S. (1989) Biochemistry, 28, 8060-8066.
33. Shou, M.; Korzekwa, K.R.; Crespi, C.L.; Gonzalez, F.J. and Gelboin, H.V. (1994) Mol. Carcinog., 10, 159-168.
34. Omiecinski, C.J.; Redlich, C.A. and Costs, P. (1990) Cancer Res., 50, 4315-4321.
35. McLemore. T.L.; Adelberg, S.; Liu, M.C.; McMahon, N.A.; Yu, S.J.; Hubbard, W.C.; Czerwinski, M.; Wood, T.G.; Storeng, R.; Luber; R.A.; Eggleston, J.C.; Boyd, M.R. and Hines, R.N. (1990) J. Natl. Cancer Inst., 83, 1333-1339.
36. Anttila, S.; Hietanen, E.; Vainio, H.; Camus, A.M.; Gelboin, H.V.; Park, S.S.; Heikkila, L.; Karjalainen, A. and Bartsch, H. (1991) Int. J. Cancer, 47, 681-685.
37. Wheeler, C.W.; Park, S.S. and Guenthner, T.M. (1990) Mol. Pharmacol., 38, 634-643.
38. Anttila, S.; Vainio, H.; Hietanen, E.; Camus, A.M.; Malaveille, C.; Brun, G.; Husgafvel-Pursiainen, K., Heikkila, L.; Karjalainen, A. and Bartsch, H. (1992) Environ. Health Perspect., 98, 179-182.
39. Bartsch, H.; Castegnaro, M.; Rojas, M.; Camus, A.M.; Alexandrov, K. and Lang, M. (1992) Toxicol. Lett., 64-65, 477-483.
40. Piipari, R.; Savela, K.; Nurminen, T.; Hukkanen, J.; Raunio, H.; Hakkola, J.; Mantyla, T.; Beaune, P.; Edwards, R.J.; Boobis, A.R. and Anttila, S. (2002) Int. J. Cancer, 86, 610-616.
41. Anttila, S.; Hirvonen, A.; Husgafvel-Pursiainen, K.; Karjalainen, A.; Nurminen, T. and Vainio, H. (1994) Carcinogenesis, 15, 1133-1135.
42. Saarikoski, S.T.; Husgafvel-Pursiainen, K.; Hirvonen, A.; Vainio, H.; Gonzalez, F.J. and Anttila, S. (1998) Int. J. Cancer, 77, 33-39.
43. Vineis, P. (2002) Toxicology, 8, 457-462.
44. Bouchardy, C.; Wikman, H.; Benhamou, S.; Hirvonen, A.; Dayer, P. and Husgafvel-Pursiainen, K. (1997) Biomarkers, 2, 131-134.
45. Mollerup, S.; Berge, G.; Baera, R.; Skaug, V.; Hewer, A.; Phillips, D.H.; Stangeland, L. and Haugen, A. (2006) Int. J. Cancer, 119, 741-744.
46. Nakajima, M.; Yokoi, T.; Mizutani, M.; Kinoshita, M.; Funayam, M. and Kamataki, T. (1999) J. Biochem, (Tokyo) 125, 803-808.
47. Jiang, H.; Shen, Y.M.; Quinn, A.M. and Penning, T.M. (2005) Chem. Res. Toxicol., 18, 365-374.
48. Willey, J.C.; Coy, E.; Brolly, C.; Utell, M.J.; Frampton, M.W.; Hammersley, J.; Thilly, W.G.; Olson, D. and Cairns, K. (1996) Am. J. Respir. Cell Mol. Biol., 14, 262-271.
49. Shimada, T.; Hayes, C.L.; Yamazaki, H.; Amin, S.; Hecht, S.S.; Guengerich, F.P. and Sutter, T.R. (1996) Cancer Res., 56, 2979-2984.
50. Sutter, T.R.; Tang, Y.M.; Hayes, C.L.; Wo, Y.Y.; Jabs, E.W.; Li, X.; Yin, H.; Cody, C.W. and Greenlee, W.F. (1994) J. Biol. Chem., 269, 13092-13099.
51. Wu, M.F.; Wu, W.J.; Chang, G.C.; Chen, C.Y.; Hu, S.W.; Tsai, W.T.; Lee, H. and Lin, P. (2004) Toxicol. Lett., 150, 211-219.
52. Aklillu, E.; Ovrebo, S.; Botnen, I.V.; Otter, C. and Ingelman-Sundberg, M. (2005) Cancer Res., 65, 5105-5111.
53. Bartsch, H.; Nair, U.; Risch, A.; Rojas, M.; Wikman, H. and Alexandrov, K. (2000) Cancer Epidemol. Biomarkers Prev., 9, 3-28
54. Nebert, D.W.; Dalton, T.P.; Okey, A.B. and Gonzalez, F.J. (2004) J. Biol. Chem., 279, 23847-23850.
55. Shimada, T.; Yun, C-H.; Yamazaki, H.; Gautier, J-C.; Beaune, P.H. and Guengerich, F.P. (1992) Mol. Pharmacol., 41, 856-864.
56. Kamataki, T.; Nunoya, K.; Sakai, Y.; Kushida, H. and Fujita, K. (1999) Mutation Res., 428, 125-130.
57. Hecht, S.S. (1998) Chem. Res. Toxicol., 11, 559-603.
58. Smith, G.B.J.; Bend, J.R.; Bedard, J.J.; Reid, K.R.; Petsikas, D. and Massey, T.E. (2003) Drug Metab. Dispos., 31, 1134-1141.
59. Ruangyuttikarn, W.; Appleton, M.L. and Yost, G.S. (1991). Drug Metab. Dispos., 19, 977-984.
60. Kamataki, T.; Fujieda, M.; Kiyotani, K.; Iwano, S. and Kunitoh, H. (2005) Biochem. Biophys. Res. Commun., 338, 306-310.
61. Malaiyandi, V.; Sellers, E.M. and Tyndale, R.F. (2005) Clin. Pharmacol. Ther., 77, 145-158.
62. He, X.Y.; Tang, L.; Wang, S.L.; Cai, Q.S.; Wang, J.S. and Hong, J.Y. (2005) Int. J. Cancer, 118, 2665-2671.
63. Hukkanen, J.; Hakkola J.; Anttila, S.; Piipari, R.; Karjalainen A.; Pelkonen, O. and Raunio, H. (1997) Mol. Carcinog., 20, 224-230.
64. Czerwinski, M.; McLemore, T.L.; Gelboin, H.V. and Gonzalez, F.J. (1994) Cancer Res., 54, 1085-1091.
65. Gervot, L.; Rochat B.; Gautier, J.C.; Bohnenstengel, F.; Kroemer, H.; de Berardinis, V.; Martin, H.; Beaune, P. and de Waziers, I. (1999) Pharmacogenetics, 9, 295-306.
66. Roy, P.; Yu, L.J.; Crespi, C.L. and Waxman, DJ. (1999) Drug Metab. Dispos., 27, 655-666.
67. Kaminsky, L.S. and Spivack, S.D. (1999) Mol. Aspects Med., 20, 70-84.
68. Fujitaka, K.; Oguri, T.; Isobe, T.; Fujiwara, Y. and Kohno, N. (2001) Cancer Chemother. Pharmacol., 48, 42-46.
69. Yokose, T.; Doy, M.; Taniguchi, T.; Shimada, T., Kakiki, M.; Horie, T.; Matsuzaki, Y. and Mukai, K. (1999) Virch. Arch., 434, 401-411.
70. Nakajima, T.; Elovaara, E.; Gonzalez, F.J.; Gelboin, H.V.; Raunio, H.; Pelkonen O.; Vainio, H. and Aoyoma T. (1994) Chem. Res. Toxicol., 7, 891-896.
71. Wheeler, C.W.; Wrighton, S.A. and Guenthner, T.M. (1992) Biochem. Pharmacol., 44, 911-917.
72. Tousaaint, C.; Albin, N.; Massaad, L.; Grunenwald, D.; Parise, O. Jr.; Morizet, J; Gouyette, A. and Chabot, G.G. (1993) Cancer Res., 53, 4608-4612.
73. Bouchardy, C.; Benhamou, S. and Dayer, P. (1996) Cancer Res., 56, 251-253.
74. Kivisto, K.T.; Linder, A.; Friedel, G.; Beaune, P.; Belloc, C.; Kroemer, H. K. and Fritz, P. (1995) Virch. Arch., 426, 243-247.
75. Ronis, M.J.J.; Lindros, K.O.; Ingelman-Sundberg, M.; Ioannides, C.; Parke, D.V. editors. (1996) Cytochromes P450: Metabolic and Toxicological Aspects. 9, The CYP2E subfamily. Boca Raton, CRC Press, 1996, 211-239.
76. Dowsley, T.F.; Reid, K.; Petsikas, D.; Ulreich, J.B.; Fisher, R.L. and Forkert, P.G. (1999) J. Pharmacol. Exp. Ther., 289, 641-648.
77. Simmonds, A.C.; Reilly, C.A.; Baldwin, R.M., Ghanayem, B.I.; Lanza, D.L.; Yost, G.S.; Collins, K.S. and Forkert, P.G. (2004). Drug Metab. Dispos., 32, 1032-1039.
78. Forkert P.G.; Lee, R.P. and Reid, K. (2001) Drug Metab. Dispos., 29, 258-263.
79. Lanza, D.L.; Code, E.; Crespi, C.L.; Gonzalez, F.J. and Yost, G.S. (1999) Drug Metab. Dispos., 27, 798-803.
80. Czerwinski, M.; McLemore, T.L.; Philpot, R.M.; Nhamburo, P.T.; Korzekwa, K.; Gelboin, H.V. and Gonzalez, F.J. (1991) Cancer Res., 51, 4636-4638.
81. Thornton-Manning, J.; Appleton, M.L.; Gonzalez, F.J. and Yost, G.S. (1996) J. Pharmacol. Exp. Ther., 276, 21-29.
82. Zeldin, D.C.; Foley, J.; Ma, J.; Boyle,. J.E.; Pascual, J.M.; Moomaw, C.R.; Tomer, K.B.; Steenbergen, C. and Wu, S. (1996) Mol. Pharmacol., 50, 1111-1117.
83. Rivera, S.P.; Saarikoski, S.T. and Hankinson, O. (2002) Mol. Pharmacol., 61, 255-259.
84. Wang, S.L.; He, X.Y. and Hong, J.Y. (2005) Drug Metab. Dispos., 33, 336-340.
85. Karlgren, M.; Miura, S. and Ingelman-Sundberg, M. (2005) Taxicol. Appl. Pharmacol., 207, S57-S61.
86. Buckpitt, A.; Boland, B.; Isbell, M.; Morin, D.; Shultz, M.; Baldwin, R.; Chan, K.; Karlson, A.; Lin, C.; Taff, A.; West, J.; Fanucchi, M.; Van Winkle, L. and Plopper, C. (2002) Drug Metab. Rev., 34, 791-820.
87. Kivisto, K.T.; Fritz, P.; Linder, A.; Friedel, G.; Beaune, P. and Kroemer, H.K. (1995) Histochemistry, 103, 25-29.
88. Kivistö, K.T.; Griese, E-U.; Fritz, P.; Linder, A.; Hakkola, J.; Raunio, H.; Beaune, P. and Kroemer, H.K. (1996) Naunyn-Schmiedeberg Arch. Pharmacol., 353, 207-212.
89. Raunio, H.; Hakkola, J. and Pelkonen, O. (2005) Chem. Biol, Interact., 151, 53-62.
90. Kelly, J.D.; Eaton, D.L.; Guengerich, F.P. and Coulombe, R.A.J. (1997) Toxicol. Appl. Pharmacol., 144, 88-95.
91. Zheng, Y.M.; Fisher, M.B.; Yokotani, Fujii-Kuriyama, Y. and Rettie, A.E. (1998) Biochemistry, 37, 12847-12851.
92. Oesch, F.; Schmassmann H.; Ohnhaus, E., Althaus, U. and Lorenz, J. (1980) Carcinogenesis, 1, 827-835.
93. Benhamou; S.; Reinikanen, M.; Bouchardy, C.; Dayer, P. and Hirvonen, A. (1998) Cancer Res., 58, 5291-5293.
94. Cajas-Salazar, N.; Au, W.W.; Zwischenberger, J.B.; Sierra-Torres, CH.; Salama, S.A.; Alpard, S.K. and Tyring, S.K. (2003) Cancer Genet. Cytogenet., 145, 97-102.
95. Park, J.Y.; Chen, L.; Elahi, A.; Lazarus, P. and Tockman, M.S. (2005) Eur. J. Cancer Prev., 14, 223-230.
96. Zhang, J. and Cashman, J.R. (2006) Drug Metab Dispos., 34, 19-26.
97. Dolphin, C.T.; Beckett, D.J.; Janmohamed, A.; Cullingford, T.E.; Smith, R.L.; Shephard, E.A. and Phillips, I.R. (1998) J. Biol. Chem., 273, 30599-30607.
98. Chung, W.G.; Park, C.S.; Roh, H.K.; Lee, W.K. and Cha, Y.N. (2000) Jpn. J. Pharmacol., 84, 213-220.
99. Krueger, S.K.; Williams, D.E.; Yueh, M.F.; Martin, S.R.; Hines, R.N.; Raucy, J.L.; Dolphin, C.T.; Shephard, E.A. and Phillips, I.R. (2002) Drug Metab. Rev., 34, 523-532.
100. Krueger, S.K.; Martin, S.R.; Yueh, M.F.; Pereira, C.B. and Williams, D.E. (2002) Drug Metab. Dispos., 30, 34-41.
101. Krueger, S.K.; Siddens, L.K; Martin, S.R; Yu, Z.; Pereira, C.B.; Cabacungan, E.T.; Hines, R.N.; Ardlie, K.G.; Raucy, J.L. and Williams, D.E. (2004) Drug Metab. Dispos., 32, 1337-1340.
102. Tukey, R.H. and Strassburg, C.P. (2000) Annu. Rev. Pharmacol. Toxicol., 40, 581-616.
103. Zheng, Z.; Fang, J.L. and Lazarus, P. (2002) Drug Metab. Dispos., 30, 397-403.
104. Turgeon. D.; Carrier, J.S.; Levesque, E.; Hum, D.W. and Belanger, A. (2001) Endocrinology, 142, 778-787.
105. Kuzuya, Y.; Adachi, T.; Hara, H.; Anan, A.; Izuhara, K. and Nagai, H. (2004) IUBMB Life, 56, 355-359.
106. Ando, Y. and Hasegawa, Y. (2005) Drug Metab. Rev., 37, 565-574.
107. Oguri, T.; Takahashi, T.; Miyazaki, M.; Isobe, T.; Kohno, N.; Mackenzie, P.I. and Fujiwara, Y. (2004) Anticancer Res., 24, 2893-2896.
108. Araki, J.; Kobayashi, Y.; Iwasa, M.; Urawa, N.; Gabazza, E.C.; Taguchi, O.; Kaito, M. and Adachi, Y. (2005) Eur. J. Cancer, 41, 2360-2365.
109. Ren, Q.; Murphy, S.E.; Zheng, Z. and Lazarus, P. (2000) Drug Metab. Dispos., 28, 1352-1360.
110. Hayes, J.D. and Pulford, D.J. (1995) Crit. Rev. Biochem. Mol. Biol., 30, 445-600.
111. Pacifici, G.M.; Franchi, M.; Bencini, C.; Repetti, F.; Di Lascio, N.; Muraro, G.B. (1988) Xenobiotica, 18, 849-856.
112. Anttila, S.; Hirvonen, A.; Vainio, H.; Husgafvel-Pursiainen, K.; Hayes, J.D. and Ketterer. B. (1993) Cancer Res., 53, 5643-5648.
113. Boukouvala, S. and Sim, E. (2005) Basic Clin. Pharmacol. Toxicol., 96, 343-351.
114. Windmill, K.F.; Gaedigk, A.; Hall, P.M.; Samaratunga, H.; Grant, D.M. and McManus, M.E. (2000) Toxicol. Sci., 54, 19-29.
115. Wikman, H.; Thiel, S.; Jager, B.; Schmezer, P.; Spiegelhalder, B.; Edler, L.; Dienemann, H.; Kayser, K.; Schutz, V.; Drings, P.; Bartsch, H. and Risch, A. (2001) Pharmacogenetics, 11, 157-168.
116. Anitha, A. and Banerjee, M. (2003) Int. J. Mol. Med., 11, 125-131.
117. Wang, H.; Wagner, C.R. and Hanna, P.E. (2005) Chem. Res. Toxicol., 18, 183-197.
118. Yang, C.C.; Yang, J.H.; Lu, H.F.; Chen, S.Y.; Lin, S.Y. and Chung, J.G. (2004) Anticancer Res., 24, 1501-1506.
119. Kauffman, F.C. (2004) Drug Metab. Rev., 36, 823-843.
120. Coughtrie, M.W. (2002) Pharmacogenomics J., 2, 297-308.
121. Glatt, H. (2000) Chem. Biol. Interact, 129, 141-170.
122. He, D.; Frost, A.R. and Falany, C.N. (2005) Biochim. Biophys. Acta, 1724, 119-126.
123. Adjei, A.A.; Thomae, B.A.; Prondzinski, J.L.; Eckloff, B.W.; Wieben, E.D. and Weinshilboum, R.M. (2003) Br. J. Pharmacol., 139, 1373-1382.
124. Wang, Y.; Spitz, M.R.; Tsou, A.M.; Zhang, K.; Makan, N. and Wu, X. (2002) Lung Cancer, 35, 137-142.
125. Korytina, G.F.; Yanbaeva, D.G.; Babenkova, L.I.; Etkina, E.I. and Victorova, T.V. (2005) J. Mol. Med., 83, 700-710.
126. Ruan, Q.; Kim, H.Y.; Jiang, H.; Penning, T.M.; Harvey, R.G. and Blair, I. A. (2006) Rapid Commun. Mass Spectrom., 20, 1369-1380.
127. Ruan, Q.; Glehaus, S.L.; Penning, T.M.; Harvey, R.G. and Blair, I. A. (2006) Chem. Res. Toxicol., in review.
128. Palackal, N.T.; Lee, S.H.; Harvey, R.G.; Blair, I. A. and Penning, T.M. (2002) J. Biol. Chem., 277, 24799-24808.
129. Fukumoto, S.; Yamauchi, N.; Moriguchi, H.; Hippo, Y.; Watanabe, A.; Shibahara, J.; Taniguchi, H.; Ishikawa, S.; Ito, H.; Yamamoto, S.; Iwanari, H.; Hironaka, M.; Ishikawa, Y.; Niki, T.; Sohara, Y.; Kodama, T.; Nishimura, M.; Fukayama, M.; Dosaka-Akita, H. and Aburatani, H. (2005) Clin. Cancer Res., 11, 1776-1785.
130. Nagaraj, N.S.; Beckers, S.; Mensah, J.K.; Waigel, S.; Vigneswaran, N. and Zacharias, W. (2006) Toxicol. Lett., 165, 182-194.
131. Woenckhaus, M.; Klein-Hitpass, L.; Grepmeier, U.; Merk, J.; Pfeifer, M.; Wild, P.; Bettstetter, M.; Wuensch, P.; Blaszyk, H.; Hartmann, A.; Hofstaedter, F. and Dietmaier, W. (2006) J. Pathol., Aug 16 [Epub ahead of print]; DOI: 10.1002/peth.2039.
132. Jiang, H.; Vudathala, D.K.; Blair, I.A. and Penning, T.M. (2006) Chem. Res. Toxicol., 19, 68-78.
133. Park, J.H.; Gopishetty, S.; Szewczuk, L.M., Troxel, A.B.; Harvey, R.G. and Penning, T.M. (2005) Chem. Res. Toxicol., 18, 1026-1037.